Intel Warns US Equity Stake Could Trigger 'Adverse Reactions'

Intel said Monday that converting $8.87 billion in federal chip subsidies into a 10% equity stake creates unprecedented complications and potential "adverse reactions" for a company deriving 76% of revenue internationally. The arrangement transforms Biden-era CHIPS Act grants into share purchases at $20.74 -- a discount to Friday's $24.80 close -- with the Department of Commerce receiving up to 433 million shares by Tuesday's expected closing. Foreign governments may impose additional regulations on Intel due to US government ownership, the company warned in securities filings, while the precedent could discourage other nations from offering grants if they expect similar equity conversions. China alone represents 29% of Intel's revenue. The deal also restricts Intel's strategic flexibility, requiring government votes align with board recommendations except on matters affecting federal interests.

Read more of this story at Slashdot.